Screening for Cryptosporidium/Giardia by EIA

Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect. Similarly, Giardia infection is frequently misdiagnosed, relying on poorly performing antigen-based testing.

Pro-Lab Diagnostics’ Prolisa Cryptosporidium/Giardia enzyme immunoassay (EIA) is a convenient, rapid and easy-to-use method for detecting Cryptosporidium and Giardia lamblia. Supplied in a 96-well test size consisting of detachable stripwells, this manual assay uses monoclonal anti-Cryptosporidium and anti-G. lamblia antibodies to ensure excellent sensitivity and specificity for high-value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility.

Mark Reed, General Manager of Pro-Lab Diagnostics, commented: “The Cryptosporidium/Giardia EIA is an important part of the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for cryptosporidiosis and giardiasis, with the back-up support of our team of application experts.”


Other news

Upcoming Events


Technological University Dublin
3-4 September 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Jun 2019

Recent advances in cancer diagnostics

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.